Loading...
The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy.
Dave, R O'Connell, R Rattay, T Tolkien, Z Barnes, N Skillman, J Williamson, P Conroy, E Gardiner, M Harnett, A
Dave, R
O'Connell, R
Rattay, T
Tolkien, Z
Barnes, N
Skillman, J
Williamson, P
Conroy, E
Gardiner, M
Harnett, A
Citations
Altmetric:
Abstract
Immediate breast reconstruction (IBR) is routinely offered to improve quality of life for women with breast cancer requiring a mastectomy, but there are concerns that more complex surgery may delay the delivery of adjuvant oncological treatments and compromise long-term oncological outcomes. High-quality evidence, however, is lacking. iBRA-2 is a national prospective multicentre cohort study that aims to investigate the effect of IBR on the delivery of adjuvant therapy.
Description
Date
2016-10-07
Publisher
Collections
Files
Keywords
Type
Article
Citation
The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy. 2016, 6 (10):e012678 BMJ Open